ÂÜÀòÂÒÂ×

Raoul Oostenbrink has a diverse range of work experience in various organizations and roles. Starting in 2004, they worked at Teleflex Incorporated as the VP Sales and Marketing, where they focused on developing cardiac function analysis monitors. In 2013, they joined TNO as a Senior Business Developer, specializing in the medical domain. From 2015 to 2017, they served as a Funding Manager at RoboValley, promoting the development of new robot technology. Raoul then worked at NWO as a Business Development Manager from 2014 to 2017, coordinating the business incubation-acceleration program for the NanoNextNL consortium. In 2017, they took on multiple roles, including being the Director of Business Development at LipoCoat BV, Coordinator at Business Cluster Nanotechnology, and Managing Director at both Mesa+ and NanoLabNL at the University of Twente. In 2018, Raoul became a Business Development Consultant at Diabetes Fonds, and in 2021, they became a Senior Program Manager at Quantum Delta NL, focusing on quantum technology commercialization. Currently, Raoul is a Principal at IVX4 | Innovation Value eXchange, an innovation brokerage firm that specializes in catalyzing knowledge into commercially viable businesses.

Raoul Oostenbrink has a diverse educational background. Raoul obtained a Bachelor's degree in Marketing from Rotterdam Business School, where they studied from 1991 to 1996. During their time at Rotterdam Business School, they also pursued a Bachelor's degree in International Business at the University of Georgia - Terry College of Business from 1994 to 1995.

In 1996, Raoul Oostenbrink enrolled at Vrije Universiteit Amsterdam (VU Amsterdam) and completed a Master of Arts (MA) degree in Culture, Organization, and Management in 1999. Additionally, in 1992 and 1993, they studied psychology at Leiden University.

In terms of certifications, Raoul Oostenbrink obtained the NEN-EN-ISO 13485 and NEN-EN-ISO 14971 certifications from NEN in November 2007. Raoul also holds the Prince 2 Practitioner certification from APMG-International, which they achieved in November 2007.